Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis

NCT04920851 is registered in ClinicalTrials.gov with Derince Training and Research Hospital as lead sponsor.

NCT NCT04920851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis
Lead sponsor
Derince Training and Research Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 10, 2021
Completion date
July 20, 2021
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interleukin 6